Seven Bridge Financial Group, LLC Amgen Inc Transaction History

Seven Bridge Financial Group, LLC

$552 Million
Q3 2024

A detailed history of Seven Bridge Financial Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Seven Bridge Financial Group, LLC holds 18,526 shares of AMGN stock, worth $5.33 Million. This represents 1.08% of its overall portfolio holdings.

Number of Shares

18,526

Previous 17,447 6.18%

Holding current value

$5.33 Million

Previous $5.45 Million 9.5%

% of portfolio

1.08%

Previous 1.17%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$309.38 - $337.38 $333,821 - $364,033	1,079 Added 6.18%	18,526 $5.97 Million
Q2 2024 Aug 09, 2024	BUY	$262.75 - $319.31 $141,096 - $171,469	537 Added 3.18%	17,447 $5.45 Million
Q1 2024 May 10, 2024	SELL	$268.87 - $324.56 $78,241 - $94,446	-291 Reduced 1.69%	16,910 $4.81 Million
Q4 2023 Jan 22, 2024	BUY	$255.7 - $288.46 $4,346 - $4,903	17 Added 0.1%	17,201 $4.95 Million
Q3 2023 Oct 25, 2023	BUY	$218.65 - $271.46 $155,897 - $193,550	713 Added 4.33%	17,184 $4.62 Million
Q2 2023 Jul 26, 2023	SELL	$214.27 - $253.37 $17,141 - $20,269	-80 Reduced 0.48%	16,471 $3.66 Million
Q1 2023 Apr 20, 2023	BUY	$225.79 - $275.2 $22,127 - $26,969	98 Added 0.6%	16,551 $4 Million
Q4 2022 Jan 26, 2023	BUY	$229.03 - $291.01 $57,486 - $73,043	251 Added 1.55%	16,453 $0
Q3 2022 Oct 17, 2022	BUY	$224.46 - $253.15 $89,335 - $100,753	398 Added 2.52%	16,202 $3.65 Million
Q2 2022 Jul 12, 2022	SELL	$230.71 - $256.74 $68,290 - $75,995	-296 Reduced 1.84%	15,804 $3.85 Million
Q1 2022 Apr 15, 2022	SELL	$219.27 - $242.57 $112,046 - $123,953	-511 Reduced 3.08%	16,100 $3.89 Million
Q4 2021 Jan 20, 2022	BUY	$198.88 - $227.6 $3.3 Million - $3.78 Million	16,611 New	16,611 $3.74 Million
Q4 2021 Jan 20, 2022	SELL	$198.88 - $227.6 $3.33 Million - $3.82 Million	-16,762 Closed	0 $0
Q3 2021 Oct 14, 2021	SELL	$212.27 - $248.7 $140,735 - $164,888	-663 Reduced 3.8%	16,762 $3.56 Million
Q2 2021 Jul 26, 2021	BUY	$233.58 - $259.14 $61,197 - $67,894	262 Added 1.53%	17,425 $4.25 Million
Q1 2021 Apr 20, 2021	BUY	$221.91 - $258.6 $14,202 - $16,550	64 Added 0.37%	17,163 $4.27 Million
Q4 2020 Jan 19, 2021	BUY	$216.38 - $257.67 $71,621 - $85,288	331 Added 1.97%	17,099 $3.93 Million
Q3 2020 Oct 22, 2020	SELL	$234.65 - $260.95 $3,050 - $3,392	-13 Reduced 0.08%	16,768 $4.26 Million
Q2 2020 Jul 24, 2020	BUY	$197.81 - $242.74 $36,792 - $45,149	186 Added 1.12%	16,781 $3.96 Million
Q1 2020 Apr 16, 2020	BUY	$182.24 - $241.7 $38,634 - $51,240	212 Added 1.29%	16,595 $3.36 Million
Q4 2019 Jan 17, 2020	SELL	$189.21 - $243.2 $44,842 - $57,638	-237 Reduced 1.43%	16,383 $3.95 Million
Q3 2019 Oct 09, 2019	SELL	$174.11 - $208.62 $11,317 - $13,560	-65 Reduced 0.39%	16,620 $3.22 Million
Q2 2019 Jul 15, 2019	BUY	$166.7 - $195.41 $26,672 - $31,265	160 Added 0.97%	16,685 $3.08 Million
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $15,193 - $17,125	84 Added 0.51%	16,525 $3.14 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $17,840 - $20,825	100 Added 0.61%	16,441 $3.2 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $31,314 - $35,302	169 Added 1.05%	16,341 $3.39 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $664 - $746	4 Added 0.02%	16,172 $2.99 Million
Q1 2018 May 11, 2018	BUY	$169.43 - $198.0 $64,044 - $74,844	378 Added 2.39%	16,168 $2.76 Million
Q4 2017 Feb 20, 2018	BUY	$168.79 - $188.59 $8,945 - $9,995	53 Added 0.34%	15,790 $2.75 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $89,667 - $102,376	536 Added 3.53%	15,737 $2.93 Million
Q2 2017 Aug 14, 2017	BUY	N/A	15,201	15,201 $2.62 Million

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Bridge Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seven Bridge Financial Group, LLC with notifications on news.

Account

Seven Bridge Financial Group, LLC Amgen Inc Transaction History